close_game
close_game
[

biocon news

]

Latest from biocon

Paris Olympics: South Korea fumes after its athletes introduced as North Korean

South Korea on Saturday expressed disappointment after its athletes were incorrectly introduced as North Korean at the opening ceremony of the Paris Olympics.

The South Korean Sports ministry expressed “regret over the announcement during the opening ceremony of the 2024 Paris Olympics
Published on Jul 27, 2024 03:31 PM IST
ByShweta Kukreti

Black paint smeared on Biocon board opposing Kiran Mazumdar-Shaw's remarks

Kiran Mazumdar-Shaw said that the Karnataka job reservation bill will affect Bengaluru's position as the leading tech city.

A video, which was widely shared on social media, showed a man dressed in black applying black spray paint on at least two Biocon name boards.
Updated on Jul 22, 2024 02:37 PM IST
By | Edited by

Biocon's Kiran Mazumdar-Shaw's ‘donations’ clarification on electoral bonds

Kiran Mazumdar-Shaw said that she purchased electoral bonds on a personal level to fund election campaigns.

Biocon's Kiran Mazumdar-Shaw's ‘donations’ clarification on electoral bonds
Updated on Mar 18, 2024 10:33 AM IST

Bengaluru to get 3D-printed post office, Kiran Mazumdar-Shaw reacts

The post office was proposed back in August and was completed within a month, however, now that work has begun, it is being constructed at an accelerated rate.

The post office is being built by Larsen & Toubro Limited (L&T) at the Cambridge Layout in Ulsoor.(Marisha Thakur/Twitter)
Published on Apr 11, 2023 01:09 PM IST

Biocon Biologics gets license to manufacture antibody therapy for Covid-19

US-based Adagio Therapeutics has allowed the company to manufacture and commericalise the ADG20-based treatment in India, as well as in select markets.

Biocon (Hemant Mishra/Mint File Photo)
Published on Jul 26, 2021 09:18 PM IST
By | Written by Karan Manral, New Delhi

Sebi bars Biocon official for insider trading for 3 months

Shreehas P Tambe, Biocon's senior vice president, traded in the shares of the company between December 19-27, 2017, in violation of market norms.

Biocon's Tambe gave a declaration that he is not in possession of UPSI at the time of applying for pre-clearance of trades from a compliance officer. (File Photo)
Published on Jul 02, 2021 11:08 AM IST
By | Written by Meenakshi Ray, New Delhi

Biocon Q3 net profit falls 19% to 186.6 cr

The company had posted a profit of ₹230.3 crore for the corresponding period of the previous fiscal.

The company's revenue from operations rose to <span class='webrupee'>₹</span>1,851 crore for the quarter under consideration, up 7.81 per cent, as against <span class='webrupee'>₹</span>1,716.8 crore during the same period a year ago(Biocon/Twitter)
Published on Jan 22, 2021 12:19 PM IST
PTI | , Mumbai
SHARE
Story Saved
Live Score
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Monday, October 07, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On